Biotech News
Medicenna Therapeutics Announces Participation in Upcoming Conferences
ir.medicenna.com2026-05-06 15:27 EST
TORONTO and HOUSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases is pleased to